Jenkintown, PA, United States of America

Laura Sepp-Lorenzino

This inventor holds 13 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: Alnylam Pharmaceuticals, Inc., Sloan-Kettering Institute for Cancer Research, Sirna Therapeutics, Inc.. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laura Sepp-Lorenzino. Retrieved from https://idiyas.com/inventor/laura-sepp-lorenzino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 5)

% Patents Active = 92.3

CIPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 128(Granted Patents)

Location History:

Lansdale, PA (US) (2002)
New Haven, CT (US) (2003 - 2007)
Cambridge, MA (US) (2018 - 2022)
Jenkintown, PA (US) (2019 - 2022)

Company Filing History:

5 out of 466

Alnylam Pharmaceuticals, Inc.

patents

4 out of 519

Sloan-Kettering Institute for Cancer Research

patents

2 out of 140

Sirna Therapeutics, Inc.

patents

4. 1 out of 152

Technical University of Munich

patents

5. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11529428 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2022-12-20),

2. 11324820 - Methods for the treatment of subjects having a hepatitis b virus (HBV) infection (2022-05-10),

3. 11060091 - Hepatitis B virus (HBV) iRNA compositions and methods of use thereof (2021-07-13),

4. 10933081 - Myostatin iRNA compositions and methods of use thereof (2021-03-02),

5. 10729787 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2020-08-04),

6. 10640770 - Hepatitis D virus (HDV) iRNA compositions and methods of use thereof (2020-05-05),

7. 10513703 - Hepatitis B virus (HBV) iRNA compositions and methods of use thereof (2019-12-24),

8. 10004814 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2018-06-26),

9. 7271160 - Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases (2007-09-18),

10. 7238682 - Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases (2007-07-03),

11. 6989383 - Method of treating cancer (2006-01-24),

12. 6670348 - Methods and compositions for destruction of selected proteins (2003-12-30),

13. 6482851 - Synthesis of dysidiolide and uses thereof (2002-11-19),

Title: The Innovative Mind of Laura Sepp-Lorenzino

Introduction: Laura Sepp-Lorenzino is a pioneering inventor based in Jenkintown, Pennsylvania, known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Laura Sepp-Lorenzino holds several patents in the area of gene editing technologies, with her most recent patent focusing on a novel method for targeted gene therapy in treating genetic disorders.

Career Highlights: With a background in molecular biology and biochemistry, Laura Sepp-Lorenzino has dedicated her career to developing innovative solutions for complex medical challenges. Her work has led to significant advancements in the field of personalized medicine.

Collaborations: Throughout her career, Laura Sepp-Lorenzino has collaborated with leading research institutions and biopharmaceutical companies to further the development and application of her inventions. Her collaborative efforts have resulted in the successful translation of her research into tangible medical solutions.

Conclusion: Laura Sepp-Lorenzino's passion for innovation and commitment to improving healthcare through cutting-edge technologies have solidified her reputation as a trailblazing inventor in the field of biotechnology. Her contributions continue to inspire future generations of inventors and researchers in the pursuit of groundbreaking discoveries.

Profile summary based on public USPTO records.